These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35028500)

  • 1. Erratum:
    Dardas S; Khan A
    Eur Heart J Case Rep; 2022 Jan; 6(1):ytab503. PubMed ID: 35028500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial flutter with flecainide-induced 1:1 conduction at a rate <200 b.p.m. at rest: a case report.
    Dardas S; Khan A
    Eur Heart J Case Rep; 2021 Oct; 5(10):ytab396. PubMed ID: 34703982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial flutter with 1:1 AV conduction during intravenous flecainide treatment].
    Heldal M; Orning OM
    Tidsskr Nor Laegeforen; 1989 Aug; 109(23):2309-10. PubMed ID: 2505404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1:1 atrial flutter induced by flecainide, whilst the patient was at rest.
    Comelli I; Pigna F; Cervellin G
    Am J Emerg Med; 2018 Nov; 36(11):2131.e3-2131.e5. PubMed ID: 30033133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum:
    Eur Heart J Case Rep; 2022 Apr; 6(4):ytac140. PubMed ID: 35434514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion.
    Colangelo T; Johnson D; Ho R
    Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
    Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
    Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum:
    Eur Heart J Case Rep; 2022 Apr; 6(4):ytac132. PubMed ID: 35434513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal intractable atrial flutter successfully treated with intravenous flecainide.
    Suzumura H; Nitta A; Ono M; Arisaka O
    Pediatr Cardiol; 2004; 25(2):154-6. PubMed ID: 14681740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
    Crijns HJ; Van Gelder IC; Kingma JH; Dunselman PH; Gosselink AT; Lie KI
    Eur Heart J; 1994 Oct; 15(10):1403-8. PubMed ID: 7821320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
    Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
    J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
    Inoue H; Yamashita T; Nozaki A; Sugimoto T
    J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide.
    Ahsan A; Aldridge R; Bowes R
    Int J Cardiol; 1993 Apr; 39(1):88-90. PubMed ID: 8407013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum:
    Eur Heart J Case Rep; 2022 Sep; 6(9):ytac400. PubMed ID: 36196147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of flecainide on termination of atrial flutter by rapid atrial pacing.
    Heldal M; Orning OM
    Eur Heart J; 1993 Mar; 14(3):421-4. PubMed ID: 8458365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical case of the month. Atrial flutter with rapid ventricular response (1:1 atrioventricular conduction) caused by flecaïnide].
    Robinet S; Melon R; Piérard L
    Rev Med Liege; 2007 Dec; 62(12):701-3. PubMed ID: 18286943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects.
    Crijns HJ; de Langen CD; Grandjean JG; Bel KJ; Ebels T; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):462-70. PubMed ID: 7681509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to: A penetrating atherosclerotic ulcer rapidly growing into a saccular aortic aneurysm during treatment of leukaemia: a case report [
    Eur Heart J Case Rep; 2021 Oct; 5(10):ytab360. PubMed ID: 34622130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal Atrial Fibrillation on Flecainide Therapy.
    Gavin JL; Peigh GS; Kim SS
    Eur J Intern Med; 2020 Nov; 81():89-90. PubMed ID: 32980218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.